Intelligent Bio Solutions Inc. (NASDAQ:INBS) — Market Cap & Net Worth
Market Cap & Net Worth: Intelligent Bio Solutions Inc. (INBS)
Intelligent Bio Solutions Inc. (NASDAQ:INBS) has a market capitalization of $6.50 Million ($6.50 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28018 globally and #5697 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Intelligent Bio Solutions Inc.'s stock price $1.81 by its total outstanding shares 9077326 (9.08 Million). See Intelligent Bio Solutions Inc. (INBS) reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Intelligent Bio Solutions Inc. Market Cap History: 2020 to 2026
Intelligent Bio Solutions Inc.'s market capitalization history from 2020 to 2026. Data shows change from $16.12 Billion to $16.43 Million (-72.75% CAGR).
Index Memberships
Intelligent Bio Solutions Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.00% | #807 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #2594 of 3165 |
Weight: Intelligent Bio Solutions Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Intelligent Bio Solutions Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Intelligent Bio Solutions Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
28.34x
Intelligent Bio Solutions Inc.'s market cap is 28.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $16.12 Billion | $188.74K | -$3.71 Million | 85413.74x | N/A |
| 2021 | $3.13 Billion | $1.98 Million | -$7.04 Million | 1578.90x | N/A |
| 2023 | $36.82 Million | $1.26 Million | -$10.63 Million | 29.29x | N/A |
| 2024 | $12.71 Million | $3.11 Million | -$10.16 Million | 4.08x | N/A |
| 2025 | $86.51 Million | $3.05 Million | -$10.57 Million | 28.34x | N/A |
Competitor Companies of INBS by Market Capitalization
Companies near Intelligent Bio Solutions Inc. in the global market cap rankings as of August 3, 2026.
Key companies related to Intelligent Bio Solutions Inc. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Intelligent Bio Solutions Inc. Historical Marketcap From 2020 to 2026
Between 2020 and today, Intelligent Bio Solutions Inc.'s market cap moved from $16.12 Billion to $ 16.43 Million, with a yearly change of -72.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $16.43 Million | -81.01% |
| 2025 | $86.51 Million | +580.71% |
| 2024 | $12.71 Million | -65.48% |
| 2023 | $36.82 Million | -91.55% |
| 2022 | $435.71 Million | -86.06% |
| 2021 | $3.13 Billion | -80.61% |
| 2020 | $16.12 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of Intelligent Bio Solutions Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.50 Million USD |
| MoneyControl | $6.50 Million USD |
| MarketWatch | $6.50 Million USD |
| marketcap.company | $6.50 Million USD |
| Reuters | $6.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The compan… Read more